title: [Disorders of hemostasis in chronic renal failure and renal transplantation].
abstract: The presence of end-stage renal disease (ESRD) has been associated with profound clinical effects on hemostasis ranging from thrombosis to bleeding complications. The pathogenesis of uremic bleeding is multifactorial. It has been attributed to platelet dysfunction, the most important feature, particularly platelet-platelet and platelet-vessel wall interactions. Renal replacement therapy has helped reduce bleeding episodes, but the risk of morbidity and mortality due to hemorrhage persists. Abnormalities of blood coagulation and fibrinolysis predispose uremic patients to hypercoagulable state carrying the risk of atherosclerotic cardiovascular disease and thrombotic complications such as thrombosis of the vascular access wall. There are differences in the measurement of various hemostatic parameters in patients with ESRD concerning treatment with either hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD). Hemostatic disturbances are overlapped by changes in the coagulation/fibrinolytic system after renal transplantation (RT). Despite the etiology, renal transplant patients are at an increased risk of thromboembolic events as a consequence of prothrombotic clotting and fibrinolytic abnormalities. This hypercoagulable state is to a large extent associated with immunosuppressive drugs. This review will give a summary of views on hemostasis in patients with ESRD and after RT.
authors.affiliation: Klinicki bolnicki centar Zagreb, Klinika za anesteziologiju, reanimatologiju i intenzivno lijecenje Zagreb, Hrvatska. egoluza@gmail.com
authors.forename: Eleonora
authors.initials: E
authors.lastname: Goluza
authors.forename: Marija Grković
authors.initials: MG
authors.lastname: Topalović
authors.forename: Tvrtko
authors.initials: T
authors.lastname: Hudolin
authors.forename: Sanja
authors.initials: S
authors.lastname: Konosić
authors.forename: Iva Bacak
authors.initials: IB
authors.lastname: Kocman
authors.forename: Mladen
authors.initials: M
authors.lastname: Perić
mesh_terms: D050197:Atherosclerosis / Q000209:etiology; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001791:Blood Platelet Disorders; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects*; D013923:Thromboembolism / Q000209:etiology
chemical_list: D007166:Immunosuppressive Agents